Mairesse, Jérôme <br/><br/>
Oxytocin receptor agonist reduces perinatal brain damage by targeting microglia.  [electronic resource] 

 -  Glia  02 2019 
 - 345-359 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-1136 
<br/><br/><label>Standard No.: </label>10.1002/glia.23546  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Animals, Genetically Modified<br/>Animals, Newborn<br/>Brain--pathology<br/>Brain Injuries--chemically induced<br/>Cells, Cultured<br/>Computational Biology<br/>Diet, Protein-Restricted--adverse effects<br/>Disease Models, Animal<br/>Female<br/>Green Fluorescent Proteins--genetics<br/>Interleukin-1beta<br/>Lipopolysaccharides--toxicity<br/>Microglia--drug effects<br/>Oxytocics--therapeutic use<br/>Oxytocin--analogs & derivatives<br/>Peptide Fragments<br/>Pregnancy<br/>Prenatal Exposure Delayed Effects--chemically induced<br/>RNA, Messenger--metabolism<br/>Receptors, Oxytocin--metabolism<br/>Zebrafish